Peptide Blends · Exact presentation
AOD-9604 + CJC-1295 + Ipamorelin · 12 mg Blend
AOD-9604 + CJC-1295 + Ipamorelin · 12 mg Blend is a declared multi-component single-vial blend. Evidence for each component does not automatically establish the performance of the combination.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
Dosing & Reconstitution Guide
For a 12 mg presentation, the reference concentration of 4 mg/mL mathematically corresponds to 3 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 4 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.04 mg at this concentration.
Standard / Gradual Approach (3 mL reconstitution)
For a 12 mg presentation, the reference concentration of 4 mg/mL mathematically corresponds to 3 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 4 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.04 mg at this concentration.
Standard / Gradual Approach (3 mL reconstitution)
| Week | Daily Dose | Units (mL) |
|---|---|---|
| Week 1 | 200 mcg AOD / 100 mcg CJC / 100 mcg Ip | 10 units (0.10 mL) |
| Week 2 | 300 mcg AOD / 150 mcg CJC / 150 mcg Ip | 15 units (0.15 mL) |
| Weeks 3–12 | 400 mcg AOD / 200 mcg CJC / 200 mcg Ip | 20 units (0.20 mL) |
Reconstitution Steps
For a 12 mg presentation, the reference concentration of 4 mg/mL mathematically corresponds to 3 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 4 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.04 mg at this concentration.
Syringe Math Reference
Linked references apply to AOD-9604 + CJC-1295 + Ipamorelin · 12 mg Blend; primary sources, registries, and secondary material are identified separately.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How This Works
The proposed mechanism depends on the molecular identity and receptor systems described in the literature. A mechanism alone does not establish clinical efficacy.
Potential Benefits & Side Effects
Identity, purity, sterility, stability, and equivalence to studied products cannot be assumed. Adverse effects and interactions may be incompletely characterized.
Potential Benefits
Evidence may include preclinical findings, exploratory studies, or ongoing human trials. Findings should be interpreted according to study design, population, comparator, and source quality.
Source trail
Scientific references and source discovery
- PeptideDosages — exact AOD-9604 + CJC-1295 + Ipamorelin · 12 mg Blend entrysecondary-structure
- PubMed — literature search for AOD-9604 + CJC-1295 + Ipamorelinprimary-discovery
- ClinicalTrials.gov — study search for AOD-9604 + CJC-1295 + Ipamorelintrial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference